SCHEMBL9000722

SCHEMBL9000722

CCCCOc1ccc(CSC(C(=O)Nc2c(SC)cc(C)nc2SC)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ TP53 P04637 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ GPR88 Q9GZN0 2/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ XIAP P98170 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ ACAT1 P24752 1/20 0.33
▸ P2RX3 P56373 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9000714 0.92 GPR88 (0.39) SMN1; SMN2TP53NPC1RAB9AMAPT
SCHEMBL9000601 0.91 PLA2G2A (0.37) SMN1; SMN2TP53NPC1RAB9AMAPT
SCHEMBL9000831 0.87 TOP2A (0.37) SMN1; SMN2RAB9AMAPTLMNA
SCHEMBL9000603 0.87 SOAT1 (0.35) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL9000890 0.86 SOAT1 (0.43) SMN1; SMN2TP53NPC1RAB9AMAPT
SCHEMBL9000768 0.84 EPHX1 (0.41) SMN1; SMN2MAPTLMNAL3MBTL1
SCHEMBL9000878 0.82 EPHX1 (0.41) SMN1; SMN2MAPTLMNAL3MBTL1CYP2C19
SCHEMBL9000588 0.82 EPHX1 (0.38) LMNAL3MBTL1CYP2C19
SCHEMBL9000398 0.82 EPHX1 (0.47) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL9000898 0.81 EPHX1 (0.46) TP53NPC1RAB9AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583147-A INHIBITORS OF ACYL-COENZYME A: CHOLESTEROL O-TRANSFERASE; ANTIHYPERCHOLESTEROLEMIC AND/OR ANTIATHEROSCLEROTIC AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-10 — — US disclosed
Send feedback